A clinical trail to study the effectiveness of homoeopathic drugs in patient of acute and recurrent URTIs.

Phase 3

• Conditions: Health Condition 1: J069- Acute upper respiratory infection,unspecified

• Registration Number: CTRI/2021/05/033810
• Lead Sponsor: I

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Patients fulfilling the diagnostic criteria and standard case definition of acute and recurrent URTIs.

2. Patients of 03 - 25 years of age groups of various socioeconomic groups will be included.

3. Patients of both sexes will be included in the study.

4. Patient without any other systemic diseases.

5. Patient giving written consent form.

Exclusion Criteria

1. That doesnâ??t fulfil the diagnostic criteria.

2. Patients of regular medical care for any other chronic conditions like congenital malformation of respiratory tract, specific lungs disease.

3. Patients undertaking immune suppressive therapy will be excluded.

4. Patients with Psychiatric diagnosis.

5. Recent major surgery.

6. Patients requiring emergency medical care.

7. Patients who have participated in any other Research study in the last 6 months.

8. Those under other medications. Or using any other medicine during the study period.

9. Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 before and after the treatment. <br/ ><br> <br/ ><br>2. To investigate the utility and efficacy of homoeopathic medicine for the treatment of acute and recurrent URTIs.Timepoint: 1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 at day 1 and again after every 15 days, for the total of 3 months. <br/ ><br> <br/ ><br>2. Quality of life questionnaire assessment will be done in every follow-up for 3 months. <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
To observe the changes in quality of life of patient with acute and recurrent URTIs after taking treatment.Timepoint: Assessment on day 1 and after 3 months. <br/ ><br>